vs

Side-by-side financial comparison of Apyx Medical Corp (APYX) and INTERGROUP CORP (INTG). Click either name above to swap in a different company.

Apyx Medical Corp is the larger business by last-quarter revenue ($19.2M vs $17.3M, roughly 1.1× INTERGROUP CORP). INTERGROUP CORP runs the higher net margin — 8.8% vs -6.8%, a 15.5% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs 19.8%). INTERGROUP CORP produced more free cash flow last quarter ($-481.0K vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 7.8%).

Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.

Intergroup Corp is a diversified holding firm operating two core segments: real estate and hotel operations. It owns, manages and leases commercial and residential properties across the U.S., and runs limited-service hotels for leisure and business travelers.

APYX vs INTG — Head-to-Head

Bigger by revenue
APYX
APYX
1.1× larger
APYX
$19.2M
$17.3M
INTG
Growing faster (revenue YoY)
APYX
APYX
+14.9% gap
APYX
34.7%
19.8%
INTG
Higher net margin
INTG
INTG
15.5% more per $
INTG
8.8%
-6.8%
APYX
More free cash flow
INTG
INTG
$2.3M more FCF
INTG
$-481.0K
$-2.8M
APYX
Faster 2-yr revenue CAGR
APYX
APYX
Annualised
APYX
36.8%
7.8%
INTG

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
APYX
APYX
INTG
INTG
Revenue
$19.2M
$17.3M
Net Profit
$-1.3M
$1.5M
Gross Margin
62.6%
Operating Margin
0.1%
11.6%
Net Margin
-6.8%
8.8%
Revenue YoY
34.7%
19.8%
Net Profit YoY
71.9%
155.6%
EPS (diluted)
$0.71

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APYX
APYX
INTG
INTG
Q4 25
$19.2M
$17.3M
Q3 25
$12.9M
$17.9M
Q2 25
$11.4M
$16.2M
Q1 25
$9.4M
$16.8M
Q4 24
$14.2M
$14.4M
Q3 24
$11.5M
$16.9M
Q2 24
$12.1M
$13.4M
Q1 24
$10.2M
$14.9M
Net Profit
APYX
APYX
INTG
INTG
Q4 25
$-1.3M
$1.5M
Q3 25
$-2.0M
$-535.0K
Q2 25
$-3.8M
$-2.2M
Q1 25
$-4.2M
$-578.0K
Q4 24
$-4.6M
$-2.7M
Q3 24
$-4.7M
$-398.0K
Q2 24
$-6.6M
$-4.9M
Q1 24
$-7.6M
$-3.2M
Gross Margin
APYX
APYX
INTG
INTG
Q4 25
62.6%
Q3 25
64.4%
Q2 25
62.3%
Q1 25
60.1%
Q4 24
63.0%
Q3 24
60.5%
Q2 24
61.7%
Q1 24
58.1%
Operating Margin
APYX
APYX
INTG
INTG
Q4 25
0.1%
11.6%
Q3 25
-6.5%
15.3%
Q2 25
-22.6%
8.1%
Q1 25
-32.4%
14.0%
Q4 24
-21.4%
5.9%
Q3 24
-31.6%
18.5%
Q2 24
-45.7%
3.7%
Q1 24
-64.6%
4.8%
Net Margin
APYX
APYX
INTG
INTG
Q4 25
-6.8%
8.8%
Q3 25
-15.4%
-3.0%
Q2 25
-33.2%
-13.9%
Q1 25
-44.0%
-3.4%
Q4 24
-32.5%
-18.9%
Q3 24
-40.9%
-2.4%
Q2 24
-54.0%
-36.7%
Q1 24
-74.0%
-21.3%
EPS (diluted)
APYX
APYX
INTG
INTG
Q4 25
$0.71
Q3 25
$-0.25
Q2 25
Q1 25
$-0.27
Q4 24
$-1.26
Q3 24
$-0.18
Q2 24
$-0.19
Q1 24
$-0.22
$-1.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APYX
APYX
INTG
INTG
Cash + ST InvestmentsLiquidity on hand
$31.7M
$7.5M
Total DebtLower is stronger
$37.5M
$233.2M
Stockholders' EquityBook value
$14.5M
$-85.2M
Total Assets
$66.8M
$101.1M
Debt / EquityLower = less leverage
2.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APYX
APYX
INTG
INTG
Q4 25
$31.7M
$7.5M
Q3 25
$25.1M
$6.0M
Q2 25
$29.3M
$6.1M
Q1 25
$31.0M
$4.8M
Q4 24
$31.7M
$15.4M
Q3 24
$28.0M
$12.2M
Q2 24
$32.7M
$11.6M
Q1 24
$37.3M
$19.5M
Total Debt
APYX
APYX
INTG
INTG
Q4 25
$37.5M
$233.2M
Q3 25
$37.5M
$237.8M
Q2 25
$37.5M
$240.5M
Q1 25
$37.5M
$241.5M
Q4 24
$37.5M
$227.2M
Q3 24
$37.5M
$218.1M
Q2 24
$225.7M
Q1 24
$225.0M
Stockholders' Equity
APYX
APYX
INTG
INTG
Q4 25
$14.5M
$-85.2M
Q3 25
$5.8M
$-86.7M
Q2 25
$7.3M
$-86.1M
Q1 25
$10.5M
$-84.5M
Q4 24
$14.2M
$-83.9M
Q3 24
$11.0M
$-80.9M
Q2 24
$14.7M
$-80.3M
Q1 24
$20.3M
$-76.4M
Total Assets
APYX
APYX
INTG
INTG
Q4 25
$66.8M
$101.1M
Q3 25
$57.4M
$102.5M
Q2 25
$58.2M
$104.1M
Q1 25
$60.2M
$103.2M
Q4 24
$64.8M
$110.6M
Q3 24
$60.7M
$109.3M
Q2 24
$65.4M
$107.8M
Q1 24
$70.7M
$119.0M
Debt / Equity
APYX
APYX
INTG
INTG
Q4 25
2.58×
Q3 25
6.41×
Q2 25
5.17×
Q1 25
3.57×
Q4 24
2.64×
Q3 24
3.40×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APYX
APYX
INTG
INTG
Operating Cash FlowLast quarter
$-2.5M
$-23.0K
Free Cash FlowOCF − Capex
$-2.8M
$-481.0K
FCF MarginFCF / Revenue
-14.6%
-2.8%
Capex IntensityCapex / Revenue
1.4%
2.6%
Cash ConversionOCF / Net Profit
-0.02×
TTM Free Cash FlowTrailing 4 quarters
$-9.1M
$739.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APYX
APYX
INTG
INTG
Q4 25
$-2.5M
$-23.0K
Q3 25
$-3.5M
$-296.0K
Q2 25
$-1.2M
$5.9M
Q1 25
$-702.0K
$-854.0K
Q4 24
$-2.9M
$-781.0K
Q3 24
$-4.4M
$3.4M
Q2 24
$-4.3M
$6.8M
Q1 24
$-6.3M
$1.9M
Free Cash Flow
APYX
APYX
INTG
INTG
Q4 25
$-2.8M
$-481.0K
Q3 25
$-4.1M
$-1.3M
Q2 25
$-1.5M
$3.6M
Q1 25
$-757.0K
$-1.2M
Q4 24
$-3.2M
$-1.1M
Q3 24
$-4.6M
$3.1M
Q2 24
$-4.6M
$2.7M
Q1 24
$-6.4M
$1.1M
FCF Margin
APYX
APYX
INTG
INTG
Q4 25
-14.6%
-2.8%
Q3 25
-31.5%
-7.1%
Q2 25
-13.2%
22.5%
Q1 25
-8.0%
-6.8%
Q4 24
-22.4%
-7.8%
Q3 24
-40.0%
18.3%
Q2 24
-38.0%
20.4%
Q1 24
-62.2%
7.6%
Capex Intensity
APYX
APYX
INTG
INTG
Q4 25
1.4%
2.6%
Q3 25
4.0%
5.4%
Q2 25
2.3%
13.9%
Q1 25
0.6%
1.8%
Q4 24
1.7%
2.4%
Q3 24
1.3%
1.6%
Q2 24
2.4%
30.4%
Q1 24
0.3%
4.9%
Cash Conversion
APYX
APYX
INTG
INTG
Q4 25
-0.02×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APYX
APYX

Segment breakdown not available.

INTG
INTG

Hotel Operations$12.7M73%
Real Estate Operation$4.6M27%

Related Comparisons